Overview:
GSK Vaccines is a global market leader and the only biotechnology company that researches, develops, manufactures and distributes vaccines in Italy, with headquarters in Siena and nearby Rosia (1,500 employees in the production plant, and 450 researchers in the R&D centre, one of the company's three world centres). It develops cutting-edge technologies for the development of innovative vaccines, also in collaboration with Tuscan, national and international research institutions. Siena is a site of excellence for the production of glyco-mugated vaccines.
In addition to the meningococcal disease vaccine panel (strains A, B, C, W135 and Y), GSK's vaccine pipeline includes diphtheria, tetanus, whooping cough, hepatitis A+B, polio, haemophilus influenzae, parotitis, whooping cough, rotavirus, HPV and influenza. The Siena site also houses the GSK Vaccines Institute for Global Health, whose mission is to develop vaccines, effective and affordable, against those infectious diseases that still constitute a dramatic scourge in the poorest countries.
